Viewing Study NCT05293912

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-26 @ 10:17 PM

Ignite Modification Date: 2025-12-31 @ 7:42 AM

Study NCT ID: NCT05293912

Status: TERMINATED

Last Update Posted: 2025-03-18

First Post: 2022-03-01

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.

Sponsor: Hangzhou Sumgen Biotech Co., Ltd.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module